Public Perceptions on Breast Implant-Associated Anaplastic Large Cell Lymphoma.
Journal
Plastic and reconstructive surgery
ISSN: 1529-4242
Titre abrégé: Plast Reconstr Surg
Pays: United States
ID NLM: 1306050
Informations de publication
Date de publication:
07 2020
07 2020
Historique:
entrez:
27
6
2020
pubmed:
27
6
2020
medline:
15
8
2020
Statut:
ppublish
Résumé
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has entered the spotlight, as several high-profile media outlets have begun to relay the evolving science to the public. This study aimed to gauge the baseline knowledge and concern regarding BIA-ALCL among adult laywomen within the United States. Mechanical Turk was used to survey 500 American women on self-reported demographics, prior experience with breast implants, and 11 questions regarding their knowledge and concern regarding BIA-ALCL. Responses were reviewed for quality control before study inclusion. Overall, 12 percent of respondents had received breast implants and 73 percent knew someone with implants; 13.6 percent of respondents (including 51.7 percent of respondents with implants) had previously heard of BIA-ALCL. After providing information about its risk, 58.4 percent of respondents were still willing to receive a reconstructive implant and 45.8 percent a cosmetic implant; 35.8 percent reported they would be less likely to receive an implant. Of the respondents with breast implants, 66.7 percent reported some degree of concern regarding BIA-ALCL and 35.0 percent are strongly considering removing their implants. Those who had heard of BIA-ALCL consumed information from several sources, predominantly health professionals or media/health care blogs. Different sources of information were not associated with a respondent's degree of concern. Only a minority of American women have heard of BIA-ALCL and understand its association with breast implants. As plastic surgeons who perform breast reconstruction, we can promote the spread of information through the popular media and health care blogs to address this growing concern, particularly among women with existing breast implants.
Sections du résumé
BACKGROUND
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) has entered the spotlight, as several high-profile media outlets have begun to relay the evolving science to the public. This study aimed to gauge the baseline knowledge and concern regarding BIA-ALCL among adult laywomen within the United States.
METHODS
Mechanical Turk was used to survey 500 American women on self-reported demographics, prior experience with breast implants, and 11 questions regarding their knowledge and concern regarding BIA-ALCL. Responses were reviewed for quality control before study inclusion.
RESULTS
Overall, 12 percent of respondents had received breast implants and 73 percent knew someone with implants; 13.6 percent of respondents (including 51.7 percent of respondents with implants) had previously heard of BIA-ALCL. After providing information about its risk, 58.4 percent of respondents were still willing to receive a reconstructive implant and 45.8 percent a cosmetic implant; 35.8 percent reported they would be less likely to receive an implant. Of the respondents with breast implants, 66.7 percent reported some degree of concern regarding BIA-ALCL and 35.0 percent are strongly considering removing their implants. Those who had heard of BIA-ALCL consumed information from several sources, predominantly health professionals or media/health care blogs. Different sources of information were not associated with a respondent's degree of concern.
CONCLUSIONS
Only a minority of American women have heard of BIA-ALCL and understand its association with breast implants. As plastic surgeons who perform breast reconstruction, we can promote the spread of information through the popular media and health care blogs to address this growing concern, particularly among women with existing breast implants.
Identifiants
pubmed: 32590638
doi: 10.1097/PRS.0000000000006889
pii: 00006534-202007000-00006
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
30-37Commentaires et corrections
Type : CommentIn
Type : CommentIn
Références
Kim B, Roth C, Chung KC, et al. Anaplastic large cell lymphoma and breast implants: A systematic review. Plast Reconstr Surg. 2011;127:2141–2150.
Keech JA Jr, Creech BJ. Anaplastic T-cell lymphoma in proximity to a saline-filled breast implant. Plast Reconstr Surg. 1997;100:554–555.
Dixon JM, Clemens M. Breast implants and anaplastic large cell lymphoma. BMJ 2018;363:k5054.
Clemens MW, Nava MB, Rocco N, Miranda RN. Understanding rare adverse sequelae of breast implants: Anaplastic large-cell lymphoma, late seromas, and double capsules. Gland Surg. 2017;6:169–184.
Collett DJ, Rakhorst H, Lennox P, Magnusson M, Cooter R, Deva AK. Current risk estimate of breast implant-associated anaplastic large cell lymphoma in textured breast implants. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S–40S.
McCarthy CM, Loyo-Berríos N, Qureshi AA, et al. Patient registry and outcomes for breast implants and anaplastic large cell lymphoma etiology and epidemiology (PROFILE): Initial report of findings, 2012-2018. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S–73S.
Blombery P, Thompson ER, Prince HM. Molecular drivers of breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):59S–64S.
Lamaris GA, Butler CE, Deva AK, et al. Breast reconstruction following breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S–58S.
Collins MS, Miranda RN, Medeiros LJ, et al. Characteristics and treatment of advanced breast implant-associated anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):41S–50S.
Rastogi P, Riordan E, Moon D, Deva A. Theories of etiopathogenesis of breast implant-associated large cell lymphoma. Plast Reconstr Surg. 2019;143:59S–64S.
Di Napoli A. Achieving reliable diagnosis in late breast implant seromas: From reactive to anaplastic large cell lymphoma. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):15S–22S.
Miranda RN, Medeiros LJ, Ferrufino-Schmidt MC, et al. Pioneers of breast implant-associated anaplastic large cell lymphoma: History from case report to global recognition. Plast Reconstr Surg. 2019;143(A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):7S–14S.
Loch-Wilkinson A, Beath KJ, Knight RJW, et al. Breast implant-associated anaplastic large cell lymphoma in Australia and New Zealand: High-surface-area textured implants are associated with increased risk. Plast Reconstr Surg. 2017;140:645–654.
Peters W. Update on anaplastic large cell lymphoma in women with breast implants. Plast Surg (Oakv.) 2014;22:267–269.
Brody GS, Deapen D, Taylor CR, et al. Anaplastic large cell lymphoma occurring in women with breast implants: Analysis of 173 cases. Plast Reconstr Surg. 2015;135:695–705.
Cook JA, Sasor SE, Tholpady SS, Chu MW, Momeni A. Complexity of health news reporting on breast implant-associated anaplastic large cell lymphoma. Breast J. 2019;25:163–165.
Kim H, House LA, Salois M. Consumer response to media information: The case of grapefruit-medicine interaction. Health Econ Rev. 2015;5:33.
Kadin ME. What cytokines can tell us about the pathogenesis of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Suppl 1):S28–S35.
de Jong D, Vasmel WL, de Boer JP, et al. Anaplastic large-cell lymphoma in women with breast implants. JAMA2008;300:2030–2035.
Vos T, Abajobir AA, Abbafati C, et al. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: A systematic analysis for the Global Burden of Disease Study 2016. Lancet 2017;390:1211–1259.
Srinivasa DR, Miranda RN, Kaura A, et al. Global adverse event reports of breast implant-associated ALCL: An international review of 40 government authority databases. Plast Reconstr Surg. 2017;139:1029–1039.
McGuire P, Reisman NR, Murphy DK. Risk factor analysis for capsular contracture, malposition, and late seroma in subjects receiving Natrelle 410 form-stable silicone breast implants. Plast Reconstr Surg. 2017;139:1–9.
Clemens MW, Horwitz SM. NCCN consensus guidelines for the diagnosis and management of breast implant-associated anaplastic large cell lymphoma. Aesthet Surg J. 2017;37:285–289.
Clemens MW, Medeiros LJ, Butler CE, et al. Complete surgical excision is essential for the management of patients with breast implant-associated anaplastic large-cell lymphoma. J Clin Oncol. 2016;34:160–168.
Mempin M, Hu H, Chowdhury D, Deva A, Vickery K. The A, B and C’s of silicone breast implants: Anaplastic large cell lymphoma, biofilm and capsular contracture. Materials (Basel) 2018;11:E2393.
Clemens MW, Jacobsen ED, Horwitz SM. 2019 NCCN consensus guidelines on the diagnosis and treatment of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Suppl 1):S3–S13.
Butler CE, Clemens MW, Miranda RN, Lange C, Tevis SE, Hunt KK. Differences in human leukocyte antigen expression between breast implant-associated ALCL patients and the general population. Aesthetic Surg J. 2019;39:1065–1070.
Turner SD. The cellular origins of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL): Implications for immunogenesis. Aesthet Surg J. 2019;39(Suppl 1):S21–S27.
Oishi N, Miranda RN, Feldman AL. Genetics of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL). Aesthet Surg J. 2019;39(Suppl 1):S14–S20.
Erev I, Glozman I, Hertwig R. What impacts the impact of rare events. J Risk Uncertain. 2008;36:153–177.
Lin LO, Zhang RS, Mazzaferro DM, et al. Influence of repaired cleft lip and palate on layperson perception following orthognathic surgery. Plast Reconstr Surg. 2018;142:1012–1022.
Mazzaferro DM, Wes AM, Naran S, Pearl R, Bartlett SP, Taylor JA. Orthognathic surgery has a significant effect on perceived personality traits and emotional expressions. Plast Reconstr Surg. 2017;140:971–981.
Ranard BL, Ha YP, Meisel ZF, et al. Crowdsourcing: Harnessing the masses to advance health and medicine. A systematic review. J Gen Intern Med. 2014;29:187–203.